Status:
RECRUITING
Circulating Tumor Cells (CTC) in Cancer
Lead Sponsor:
University Hospital, Basel, Switzerland
Conditions:
Cancer
Eligibility:
All Genders
18+ years
Brief Summary
This observational study with circulating tumor cells (CTC) count, isolation and analysis at several time points during disease progression is to investigate the role and biology of CTCs and clusters ...
Eligibility Criteria
Inclusion
- Adult cancer patients
- All patients with histology-based proved diagnosis of cancer, all stages and subtypes can be included. Precancerous lesions cannot be included.
- All patients with the diagnosis of a solid tumor including adenocarcinoma, squamous cell carcinoma, neuroendocrine carcinoma, sarcoma
- Written pathology report must be available.
- Written informed consent.
Exclusion
- No written informed consent.
- No proved diagnosis of malignancy by pathology report.
- Patients with the diagnosis of blood cancer
Key Trial Info
Start Date :
October 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
August 1 2030
Estimated Enrollment :
3000 Patients enrolled
Trial Details
Trial ID
NCT04520672
Start Date
October 1 2020
End Date
August 1 2030
Last Update
March 12 2025
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital Basel
Basel, Switzerland, 4031
2
Department Oncology, Haematology & Immuntherapy, Kantonsspital Baselland
Liestal, Switzerland, 4410